187 GENES FOUNDi
Show / hide columns Aggregate: Custom reports Download: XML | RDF | TSV | JSON | Custom TSV/JSON Page of 4 | next »
Genei Gene descriptioni x Evidencei x Tissuei Braini Single celli Subcelli Canceri Bloodi Cell linei Struct & Inti Prognostic p-valuei x
ABCC9ATP binding cassette subfamily C member 9
Kidney Renal Clear Cell Carcinoma (validation): 1.68e-4
Colon Adenocarcinoma (TCGA): 5.18e-4
Breast Invasive Carcinoma (TCGA): 7.05e-4
ADAMTS1ADAM metallopeptidase with thrombospondin type 1 motif 1
Head and Neck Squamous Cell Carcinoma (TCGA): 7.79e-5
ADAMTS10ADAM metallopeptidase with thrombospondin type 1 motif 10
Kidney Renal Clear Cell Carcinoma (TCGA): 1.68e-5
Liver Hepatocellular Carcinoma (validation): 2.70e-4
ADAMTS4ADAM metallopeptidase with thrombospondin type 1 motif 4
Kidney Renal Papillary Cell Carcinoma (TCGA): 2.83e-8
Kidney Renal Clear Cell Carcinoma (validation): 1.97e-4
Thyroid Carcinoma (TCGA): 5.93e-4
Lung Adenocarcinoma (TCGA): 8.33e-4
ADCY3Adenylate cyclase 3
ADCY6Adenylate cyclase 6
Kidney Renal Clear Cell Carcinoma (TCGA): 1.77e-5
Kidney Renal Clear Cell Carcinoma (validation): 2.64e-4
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 5.80e-4
Liver Hepatocellular Carcinoma (validation): 8.10e-4
ADGRA2Adhesion G protein-coupled receptor A2
Kidney Renal Papillary Cell Carcinoma (TCGA): 2.42e-5
Skin Cuteneous Melanoma (TCGA): 3.97e-4
Pancreatic Adenocarcinoma (validation): 7.62e-4
Kidney Renal Clear Cell Carcinoma (validation): 9.02e-4
ADRA1DAdrenoceptor alpha 1D
ADRA2AAdrenoceptor alpha 2A
Pancreatic Adenocarcinoma (validation): 8.87e-6
Lung Adenocarcinoma (validation): 7.02e-4
ADRA2BAdrenoceptor alpha 2B
Kidney Renal Clear Cell Carcinoma (validation): 7.50e-7
Kidney Renal Clear Cell Carcinoma (TCGA): 2.53e-4
ANGPT1Angiopoietin 1
Kidney Renal Clear Cell Carcinoma (TCGA): 5.37e-6
Kidney Renal Clear Cell Carcinoma (validation): 1.12e-4
Stomach Adenocarcinoma (TCGA): 4.11e-4
ANGPT4Angiopoietin 4
AOC3Amine oxidase copper containing 3
Lung Squamous Cell Carcinoma (validation): 2.55e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.58e-4
Pancreatic Adenocarcinoma (validation): 2.99e-4
Lung Squamous Cell Carcinoma (TCGA): 9.61e-4
APOLD1Apolipoprotein L domain containing 1
Kidney Renal Clear Cell Carcinoma (TCGA): 3.91e-11
Kidney Renal Clear Cell Carcinoma (validation): 2.52e-5
ARHGAP1Rho GTPase activating protein 1
Lung Adenocarcinoma (validation): 1.52e-6
Liver Hepatocellular Carcinoma (TCGA): 3.97e-4
ARHGEF17Rho guanine nucleotide exchange factor 17
Kidney Renal Clear Cell Carcinoma (TCGA): 6.15e-4
ARHGEF25Rho guanine nucleotide exchange factor 25
Kidney Chromophobe (TCGA): 2.89e-4
Bladder Urothelial Carcinoma (TCGA): 5.30e-4
ARHGEF7Rho guanine nucleotide exchange factor 7
Kidney Renal Clear Cell Carcinoma (TCGA): 2.08e-4
Glioblastoma Multiforme (validation): 3.40e-4
Ovary Serous Cystadenocarcinoma (TCGA): 8.79e-4
ARID5AAT-rich interaction domain 5A
Breast Invasive Carcinoma (TCGA): 5.90e-4
ARTNArtemin
Kidney Renal Clear Cell Carcinoma (TCGA): 4.21e-8
AVPR1AArginine vasopressin receptor 1A
Kidney Renal Clear Cell Carcinoma (TCGA): 2.02e-5
Kidney Renal Clear Cell Carcinoma (validation): 8.06e-5
AXLAXL receptor tyrosine kinase
Ovary Serous Cystadenocarcinoma (validation): 1.96e-4
B3GNT2UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2
Kidney Renal Clear Cell Carcinoma (TCGA): 1.79e-8
Pancreatic Adenocarcinoma (TCGA): 8.55e-5
BARX1BARX homeobox 1
Head and Neck Squamous Cell Carcinoma (TCGA): 9.65e-5
Uterine Corpus Endometrial Carcinoma (TCGA): 5.12e-4
Glioblastoma Multiforme (TCGA): 8.47e-4
BCORBCL6 corepressor
Kidney Renal Clear Cell Carcinoma (TCGA): 8.67e-6
Liver Hepatocellular Carcinoma (TCGA): 2.11e-5
Kidney Renal Clear Cell Carcinoma (validation): 8.31e-4
BMP2Bone morphogenetic protein 2
Kidney Renal Clear Cell Carcinoma (TCGA): 3.73e-6
Glioblastoma Multiforme (validation): 4.32e-4
Prostate Adenocarcinoma (TCGA): 8.01e-4
C11orf96Chromosome 11 open reading frame 96
Lung Squamous Cell Carcinoma (TCGA): 1.53e-4
Liver Hepatocellular Carcinoma (validation): 4.19e-4
C1QTNF1C1q and TNF related 1
Colon Adenocarcinoma (validation): 1.21e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 3.65e-5
CABIN1Calcineurin binding protein 1
Uterine Corpus Endometrial Carcinoma (TCGA): 3.54e-4
Pancreatic Adenocarcinoma (TCGA): 5.48e-4
Kidney Renal Papillary Cell Carcinoma (TCGA): 7.35e-4
Rectum Adenocarcinoma (validation): 9.46e-4
CACNA1HCalcium voltage-gated channel subunit alpha1 H
Pancreatic Adenocarcinoma (TCGA): 2.97e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.26e-4
CCDC102BCoiled-coil domain containing 102B
CCDC3Coiled-coil domain containing 3
Pancreatic Adenocarcinoma (validation): 4.07e-4
Kidney Renal Papillary Cell Carcinoma (TCGA): 7.04e-4
Kidney Renal Clear Cell Carcinoma (validation): 9.32e-4
CCL19C-C motif chemokine ligand 19
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 1.44e-7
Kidney Renal Papillary Cell Carcinoma (TCGA): 5.71e-5
Breast Invasive Carcinoma (TCGA): 1.68e-4
CCL2C-C motif chemokine ligand 2
Glioblastoma Multiforme (TCGA): 2.24e-4
CCL26C-C motif chemokine ligand 26
Kidney Renal Clear Cell Carcinoma (TCGA): 8.55e-4
CCL8C-C motif chemokine ligand 8
CDS2CDP-diacylglycerol synthase 2
Kidney Renal Clear Cell Carcinoma (TCGA): 1.42e-7
Kidney Renal Clear Cell Carcinoma (validation): 4.10e-4
Lung Squamous Cell Carcinoma (TCGA): 8.17e-4
CH25HCholesterol 25-hydroxylase
Liver Hepatocellular Carcinoma (validation): 8.22e-5
Lung Squamous Cell Carcinoma (TCGA): 5.17e-4
CHRDChordin
CLMNCalmin
Kidney Renal Clear Cell Carcinoma (TCGA): 1.76e-7
Kidney Renal Clear Cell Carcinoma (validation): 4.54e-6
Pancreatic Adenocarcinoma (TCGA): 2.46e-4
Rectum Adenocarcinoma (validation): 4.64e-4
CNTNAP1Contactin associated protein 1
Kidney Renal Clear Cell Carcinoma (TCGA): 1.96e-6
COL18A1Collagen type XVIII alpha 1 chain
Liver Hepatocellular Carcinoma (validation): 2.71e-5
Liver Hepatocellular Carcinoma (TCGA): 2.01e-4
COL27A1Collagen type XXVII alpha 1 chain
COL4A1Collagen type IV alpha 1 chain
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.84e-6
Kidney Renal Clear Cell Carcinoma (TCGA): 1.47e-5
Lung Adenocarcinoma (validation): 2.99e-5
Kidney Renal Clear Cell Carcinoma (validation): 5.69e-4
COL4A2Collagen type IV alpha 2 chain
Kidney Renal Clear Cell Carcinoma (TCGA): 8.83e-6
Kidney Renal Clear Cell Carcinoma (validation): 7.78e-4
COX4I2Cytochrome c oxidase subunit 4I2
Kidney Renal Clear Cell Carcinoma (validation): 2.44e-6
Head and Neck Squamous Cell Carcinoma (TCGA): 1.77e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 6.03e-5
Lung Adenocarcinoma (TCGA): 7.86e-5
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 2.87e-4
CRIM1Cysteine rich transmembrane BMP regulator 1
Kidney Renal Clear Cell Carcinoma (TCGA): 7.24e-10
CRIP2Cysteine rich protein 2
Kidney Renal Clear Cell Carcinoma (TCGA): 1.54e-5
Liver Hepatocellular Carcinoma (validation): 1.13e-4
CRISPLD2Cysteine rich secretory protein LCCL domain containing 2
Liver Hepatocellular Carcinoma (validation): 2.47e-4
Page of 4 | next »